Penny Stock Pick Report is pleased to alert investors of stocks on the move. Sign Up for our Stock Newsletter
Becton, Dickinson and Co. (NYSE: BDX) will host its Q3 2009 earnings conference call on July 30, 2009 at 10am ET.
The company will release its third quarter financial results on July 30, just prior to the conference call.
The webcast of the conference call, along with related slides, will be accessible through BD’s website at http://www.bd.com/leaving/?http://www.bd.com/investors and will be available for replay through Thursday, August 6, 2009.
About Becton, Dickinson and Co.
BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people’s health throughout the world. BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD’s capabilities are instrumental in combating many of the world’s most pressing diseases. Founded in 1897 and headquartered in
Sign Up for Penny Stock Pick Report’s Free Small Cap Newsletter. To subscribe please enter your email address in the frame at the bottom of this page or visit us at our website.
Subscribe at the bottom of this page.
About Us
Penny Stock Pick Report is a leading stock web site that provides free stock alerts on stocks that are poised to make big gains. We also track small cap companies that could be on the brink of a massive breakout. To feature a company on our web site please contact us at the email listed below.
Penny Stock Pick Report is an independent electronic publication that provides information on selected publicly traded companies. This publication is not a registered investment advisor or broker-dealer. Our affiliates, officers, directors and employees may buy and sell additional shares in any company mentioned herein and may profit in the event those shares rise in value. Please do your own Due Diligence before investing in any of the stocks mentioned above. View our full disclaimer.
